Prescription medicines: applications under evaluation

22 September 2021 - The TGA has updated the list of applications for new medicines or new uses for existing ...

Read more →

1 October 2021 price disclosure confirmed prices

13 September 2021 - Confirmed 1 October 2021 prices resulting from the 2021 October cycle of price disclosure have now been ...

Read more →

Optimising the data available via Health Canada’s clinical information portal

23 August 2021 - Through its Public Release of Clinical Information initiative, Health Canada has provided public access to a vast ...

Read more →

PHARMAC must explain funding decisions

16 August 2021 - “A report this morning that all PHARMAC staff, rather than clinical experts or those with patient ...

Read more →

2021 October price disclosure cycle – indicative prices

30 August 2021 - Indicative 1 October 2021 prices resulting from the 2021 October Cycle of Price Disclosure have now ...

Read more →

PHARMAC releases drug wish-list to be more 'transparent' but advocates say it gives false hope

28 July 2021 - PHARMAC has for the first time released a list of all the drugs it wants to ...

Read more →

PHARMAC commits to being more transparent

28 July 2021 - For the first time, PHARMAC is sharing its priority lists for all funding applications for medicines ...

Read more →

Biden administration seeks higher penalties for hospitals that don't publish prices

19 July 2021 - The Biden administration is proposing to increase the penalty for hospitals that don't comply with a ...

Read more →

CMS proposes rule to increase price transparency, access to care, safety & health equity

19 July 2021 - The Centers for Medicare & Medicaid Services is proposing actions to address the health equity gap, ...

Read more →

Price disclosure 2021 October cycle outcomes summary

23 June 2021 - The summary of price disclosure price reductions for the 2021 October cycle has now been published. ...

Read more →

International regulators and WHO call for wider public access to clinical data

7 May 2021 - The International Coalition of Medicines Regulatory Authorities and the World Health Organisation are urging pharmaceutical companies to ...

Read more →

FDA scraps another last-minute Trump-era policy

30 April 2021 - The US FDA on Friday revoked a policy issued in the final days of the Trump ...

Read more →

Department of Health publishes Public Summary Document for medicine without a published outcome

8 March 2021 - The Department of Health has published a Public Summary Document for mometasone furoate with indacaterol maleate ...

Read more →

More startling revelations from the Public Summary Document for upadacitinib monohydrate (Rinvoq)

8 March 2021 - Take a seat before reading any further. ...

Read more →

The future of drug pricing transparency

11 February 2021 - A federal “Transparency in Coverage” rule requires insurers to disclose list prices and historical net prices for ...

Read more →